An enterprise Invested by SLG(Healthgen Biotech) Was Listed On the Shanghai Stock Exchange

On 28 October, Healthgen Biotechnology Corp(Healthgen Biotech). (Stock Code: 688765), an enterprise invested by SLG, was listed on the Shanghai Stock Exchange. It opened at 88 yuan on its first day of trading, marking an impressive increase of 202.82%.

Healthgen Biotech has established a comprehensive industrialisation system for Plant-Made Pharmaceutical. Its core product is Recombinant Human Albumin Injection from Oryza Sativa. From the beginning and continuing to the present, SLG has consistently supported the innovative development of Healthgen Biotech. 

In the future, SLG will continue to focus on our core businesses, which include energy conservation, water conservation, and clean energy. We will also leverage our financial resources to invest in cutting-edge fields like biotechnology, supporting promising enterprises towards a successful future.